(Q46764831)
Statements
1 reference
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial (English)
1 reference
1 reference
Eleftherios P Mamounas
1 reference
André Robidoux
1 reference
Gong Tang
1 reference
Priya Rastogi
1 reference
Charles E Geyer
1 reference
Catherine A Azar
1 reference
James N Atkins
1 reference
Louis Fehrenbacher
1 reference
Harry D Bear
1 reference
Louis Baez-Diaz
1 reference
Shakir Sarwar
1 reference
Richard G Margolese
1 reference
William B Farrar
1 reference
Adam M Brufsky
1 reference
Henry R Shibata
1 reference
Hanna Bandos
1 reference
Soonmyung Paik
1 reference
Joseph P Costantino
1 reference
Norman Wolmark
1 reference
4 October 2013
1 reference
1 reference
14
1 reference
12
1 reference
1183-1192
1 reference
Identifiers
1 reference
1 reference